Somatrogon

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameSomatrogon
Drug Alias NameHuman growth hormone-CTPSomatrogon-GHLALagovaNgenlaMOD-401 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders
Global Approved IndicationsGrowth hormone deficiencyGrowth Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2021/10/26
Country/TerritoryCzechiaBulgariaCanada +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOpko Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Ireland Pharmaceuticals LtdOpko Health IncPfizer Canada Ulc +[7] 
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A